

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in preoperative management of... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-501/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-501" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in preoperative management of esophageal adenocarcinoma" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in preoperative management of esophageal adenocarcinoma.">
            <meta name="og:description" content="Read the latest article version by Kazuto Harada, Dilsa Mizrak Kaya, Hideo Baba, Jaffer A. Ajani, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="11640">
            <meta name="article-id" content="10794">
            <meta name="dc.title" content="Recent advances in preoperative management of esophageal adenocarcinoma">
            <meta name="dc.description" content="Esophageal cancer is an aggressive malignancy with increasing incidence, and the prognosis of patients treated by surgery alone remains dismal. Preoperative treatment can modestly prolong overall survival. Preoperative chemotherapy or chemoradiation is the standard of care for resectable esophageal cancer (greater than clinical stage I and less than clinical stage IV). One of the challenges is to predict complete response in the surgical specimen from preoperative therapy and to avoid surgery in some patients but also predict ineffectiveness of preoperative therapy if the tumor is resistant and avoid such therapies altogether. In-depth understanding of the molecular biology could lead to personalized therapy, and in the future, clinical trials designed according to molecular features are expected. Here, we summarize preoperative treatment for esophageal adenocarcinoma and their potential.">
            <meta name="dc.subject" content="Esophageal cancer, preoperative therapy, personalized therapy ">
            <meta name="dc.creator" content="Harada, Kazuto">
            <meta name="dc.creator" content="Mizrak Kaya, Dilsa">
            <meta name="dc.creator" content="Baba, Hideo">
            <meta name="dc.creator" content="Ajani, Jaffer A.">
            <meta name="dc.date" content="2017/04/18">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.10794.1">
            <meta name="dc.source" content="F1000Research 2017 6:501">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Esophageal cancer">
            <meta name="prism.keyword" content=" preoperative therapy">
            <meta name="prism.keyword" content=" personalized therapy ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/04/18">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="501">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.10794.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-501">
            <meta name="citation_title" content="Recent advances in preoperative management of esophageal adenocarcinoma">
            <meta name="citation_abstract" content="Esophageal cancer is an aggressive malignancy with increasing incidence, and the prognosis of patients treated by surgery alone remains dismal. Preoperative treatment can modestly prolong overall survival. Preoperative chemotherapy or chemoradiation is the standard of care for resectable esophageal cancer (greater than clinical stage I and less than clinical stage IV). One of the challenges is to predict complete response in the surgical specimen from preoperative therapy and to avoid surgery in some patients but also predict ineffectiveness of preoperative therapy if the tumor is resistant and avoid such therapies altogether. In-depth understanding of the molecular biology could lead to personalized therapy, and in the future, clinical trials designed according to molecular features are expected. Here, we summarize preoperative treatment for esophageal adenocarcinoma and their potential.">
            <meta name="citation_description" content="Esophageal cancer is an aggressive malignancy with increasing incidence, and the prognosis of patients treated by surgery alone remains dismal. Preoperative treatment can modestly prolong overall survival. Preoperative chemotherapy or chemoradiation is the standard of care for resectable esophageal cancer (greater than clinical stage I and less than clinical stage IV). One of the challenges is to predict complete response in the surgical specimen from preoperative therapy and to avoid surgery in some patients but also predict ineffectiveness of preoperative therapy if the tumor is resistant and avoid such therapies altogether. In-depth understanding of the molecular biology could lead to personalized therapy, and in the future, clinical trials designed according to molecular features are expected. Here, we summarize preoperative treatment for esophageal adenocarcinoma and their potential.">
            <meta name="citation_keywords" content="Esophageal cancer, preoperative therapy, personalized therapy ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Kazuto Harada">
            <meta name="citation_author_institution" content="Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Holcombe Boulevard, Texas, USA">
            <meta name="citation_author_institution" content="Department of Gastroenterological Surgery, Kumamoto University, Jonjo, Kumamoto, Japan">
            <meta name="citation_author" content="Dilsa Mizrak Kaya">
            <meta name="citation_author_institution" content="Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Holcombe Boulevard, Texas, USA">
            <meta name="citation_author" content="Hideo Baba">
            <meta name="citation_author_institution" content="Department of Gastroenterological Surgery, Kumamoto University, Jonjo, Kumamoto, Japan">
            <meta name="citation_author" content="Jaffer A. Ajani">
            <meta name="citation_author_institution" content="Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Holcombe Boulevard, Texas, USA">
            <meta name="citation_publication_date" content="2017/04/18">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="501">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.10794.1">
            <meta name="citation_firstpage" content="501">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-501/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-501.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=11640 /> <input type=hidden id=articleId name=articleId value=10794 /> <input type=hidden id=xmlUrl value="/articles/6-501/v1/xml"/> <input type=hidden id=xmlFileName value="-6-501-v1.xml"> <input type=hidden id=article_uuid value=77efad69-4129-4e7f-a5ca-1922571cf1e8 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in preoperative management of esophageal adenocarcinoma"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.10794.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.10794.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-501"
  },
  "headline": "Recent advances in preoperative management of esophageal adenocarcinoma",
  "datePublished": "2017-04-18T10:43:42",
  "dateModified": "2017-04-18T10:43:42",
  "author": [
    {
      "@type": "Person",
      "name": "Kazuto Harada"
    },    {
      "@type": "Person",
      "name": "Dilsa Mizrak Kaya"
    },    {
      "@type": "Person",
      "name": "Hideo Baba"
    },    {
      "@type": "Person",
      "name": "Jaffer A. Ajani"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Esophageal cancer is an aggressive malignancy with increasing incidence, and the prognosis of patients treated by surgery alone remains dismal. Preoperative treatment can modestly prolong overall survival. Preoperative chemotherapy or chemoradiation is the standard of care for resectable esophageal cancer (greater than clinical stage I and less than clinical stage IV). One of the challenges is to predict complete response in the surgical specimen from preoperative therapy and to avoid surgery in some patients but also predict ineffectiveness of preoperative therapy if the tumor is resistant and avoid such therapies altogether. In-depth understanding of the molecular biology could lead to personalized therapy, and in the future, clinical trials designed according to molecular features are expected. Here, we summarize preoperative treatment for esophageal adenocarcinoma and their potential."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-501.html",
            "name": "Recent advances in preoperative management of esophageal adenocarcinoma"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in preoperative management of esophageal adenocarcinoma </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=11640 data-id=10794 data-downloads="" data-views="" data-scholar="10.12688/f1000research.10794.1" data-recommended="" data-doi="10.12688/f1000research.10794.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-501/v1/pdf?article_uuid=77efad69-4129-4e7f-a5ca-1922571cf1e8" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-10794-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-10794-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-10794-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Harada K, Mizrak Kaya D, Baba H and Ajani JA. Recent advances in preoperative management of esophageal adenocarcinoma [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):501 (<a class=new-orange href="https://doi.org/10.12688/f1000research.10794.1" target=_blank>https://doi.org/10.12688/f1000research.10794.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-10794-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=10794 id=track-article-signin-10794 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/10794?target=/articles/6-501.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=11640 /> <input name=articleId type=hidden value=10794 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in preoperative management of esophageal adenocarcinoma</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Kazuto Harada<a href="https://orcid.org/0000-0001-5818-7072" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-5818-7072</div><sup>1,2</sup>,&nbsp;</span><span class="">Dilsa Mizrak Kaya<sup>1</sup>,&nbsp;</span><span class="">Hideo Baba<sup>2</sup>,&nbsp;</span><span class=""><a href="mailto:jajani@mdanderson.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Jaffer A. Ajani</span></a><sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Kazuto Harada<a href="http://orcid.org/0000-0001-5818-7072" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-5818-7072</div><sup>1,2</sup>,&nbsp;</span><span class="">Dilsa Mizrak Kaya<sup>1</sup>,&nbsp;</span><span class="">Hideo Baba<sup>2</sup>,&nbsp;</span><span class=""><a href="mailto:jajani@mdanderson.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Jaffer A. Ajani</span></a><sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 18 Apr 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.10794.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Holcombe Boulevard, Texas, USA<br/> <sup>2</sup> Department of Gastroenterological Surgery, Kumamoto University, Jonjo, Kumamoto, Japan<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=22146-21902></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=22145-21900></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Esophageal cancer is an aggressive malignancy with increasing incidence, and the prognosis of patients treated by surgery alone remains dismal. Preoperative treatment can modestly prolong overall survival. Preoperative chemotherapy or chemoradiation is the standard of care for resectable esophageal cancer (greater than clinical stage I and less than clinical stage IV). One of the challenges is to predict complete response in the surgical specimen from preoperative therapy and to avoid surgery in some patients but also predict ineffectiveness of preoperative therapy if the tumor is resistant and avoid such therapies altogether. In-depth understanding of the molecular biology could lead to personalized therapy, and in the future, clinical trials designed according to molecular features are expected. Here, we summarize preoperative treatment for esophageal adenocarcinoma and their potential. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Esophageal cancer, preoperative therapy, personalized therapy </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Jaffer A. Ajani (<a href="mailto:jajani@mdanderson.org">jajani@mdanderson.org</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Jaffer A. Ajani </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This work was supported by generous grants from the Caporella, Dallas, Sultan, Park, Smith, Frazier, Oaks, Vanstekelenberg, Planjery, and Cantu Families. From the Schecter Private Foundation, Rivercreek Foundation, Kevin Fund, Myer Fund, Dio Fund, Milrod Fund, and Multidisciplinary Grants from the University of Texas M. D. Anderson Cancer Center, Houston, USA. Supported in part by the National Cancer Institute and Department of Defense awards CA138671, CA172741, CA129926, CA150334 (JAA). Supported by a grant from Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers from Japan Society for the Promotion of Science (KH). <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Harada K <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the <a href="http://creativecommons.org/publicdomain/zero/1.0/" target=_blank data-test-id=box-data-licence-link>Creative Commons Zero "No rights reserved" data waiver</a> (CC0 1.0 Public domain dedication). </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Harada K, Mizrak Kaya D, Baba H and Ajani JA. Recent advances in preoperative management of esophageal adenocarcinoma [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):501 (<a href="https://doi.org/10.12688/f1000research.10794.1" target=_blank>https://doi.org/10.12688/f1000research.10794.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 18 Apr 2017, <b>6</b>(F1000 Faculty Rev):501 (<a href="https://doi.org/10.12688/f1000research.10794.1" target=_blank>https://doi.org/10.12688/f1000research.10794.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 18 Apr 2017, <b>6</b>(F1000 Faculty Rev):501 (<a href="https://doi.org/10.12688/f1000research.10794.1" target=_blank>https://doi.org/10.12688/f1000research.10794.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d24316e274>Introduction</h2><p class="" id=d24316e277>Esophageal cancer (EC) is estimated to be the eighth most common cause of cancer in the world (456,000 cases) and the sixth most common cause of cancer death (400,000 deaths)<sup><a href="#ref-1">1</a></sup>. EC has two common histologic types: adenocarcinoma (EAC) and squamous cell carcinoma (ESCC). EAC is becoming prevalent worldwide, especially in North America and Western Europe<sup><a href="#ref-2">2</a></sup>. Esophagectomy is the most effective treatment for loco-regional control, but the 5-year survival rate after esophagectomy for locally advanced EC without preoperative treatment is less than 30%<sup><a href="#ref-3">3</a></sup>. For early-stage EC, endoscopical resection or esophagectomy without preoperative therapy is one of the available options<sup><a href="#ref-4">4</a></sup>. For the metastatic EAC, two-drug cytotoxic regimens, mainly a combination of a fluoropyrimidine and a platinum compound is recommended, and if EAC overexpresses HER2, trastuzumab should be added to chemotherapy<sup><a href="#ref-4">4</a></sup>. In case of locally advanced EC, despite radical resection, local-regional and distant recurrence develop in 33% and 20% of patients after resection, respectively<sup><a href="#ref-5">5</a></sup>. The pre-existing occult micrometastases or unresected occult local disease is responsible for relapses. Interestingly, in one study, at the time of operation, 88% of patients with EC were already found to have micro-metastases in rib marrow aspirated during esophagectomy<sup><a href="#ref-6">6</a></sup>. To overcome relapses after surgery, preoperative or postoperative treatments have been developed<sup><a href="#ref-4">4</a></sup>. Importantly, preoperative therapy can modestly prolong overall survival (OS) and increase the R0 resection rate. R0 resection is associated with a longer survival<sup><a href="#ref-7">7</a></sup>. Moreover, if preoperative therapy leads to a pathological complete response (pCR), longer OS may be expected<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>. <a href="#T1">Table 1</a> summarizes the preoperative therapy trials for EC conducted so far.</p><div class="table-wrap panel clearfix"><a name=T1 class=n-a></a><div class=caption><h3>Table 1. Key esophageal cancer trials.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d24316e338 class=n-a></a><thead><a name=d24316e340 class=n-a></a><tr><a name=d24316e342 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d24316e344 class=n-a></a>Study</th><th align=left colspan=1 rowspan=1 valign=top><a name=d24316e347 class=n-a></a>Enrolled<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d24316e352 class=n-a></a>Treatment</th><th align=left colspan=1 rowspan=1 valign=top><a name=d24316e355 class=n-a></a>Overall survival</th><th align=left colspan=1 rowspan=1 valign=top><a name=d24316e358 class=n-a></a>Hazard ratio<br class=br>(95% confidence<br class=br>interval)</th><th align=left colspan=1 rowspan=1 valign=top><a name=d24316e366 class=n-a></a><i>P</i> value</th><th align=left colspan=1 rowspan=1 valign=top><a name=d24316e371 class=n-a></a>References</th></tr></thead><tbody><a name=d24316e376 class=n-a></a><tr><a name=d24316e378 class=n-a></a><td align=left colspan=7 rowspan=1 valign=top><a name=d24316e380 class=n-a></a>Preoperative chemotherapy</td></tr><tr><a name=d24316e384 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e386 class=n-a></a>MRC OEO2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e389 class=n-a></a>802</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e392 class=n-a></a>CF → surgery (n = 400)<br class=br>Surgery (n = 402)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e397 class=n-a></a>5-year rate: 23%<br class=br>5-year rate: 17%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e402 class=n-a></a>0.84 (0.72-0.98)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e406 class=n-a></a>0.03</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e409 class=n-a></a><a href="#ref-11">11</a></td></tr><tr><a name=d24316e414 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e416 class=n-a></a>FNCLCC and<br class=br>FFCD</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e421 class=n-a></a>224</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e424 class=n-a></a>CF → surgery (n = 113)<br class=br>Surgery (n = 111)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e429 class=n-a></a>5-year rate: 38%<br class=br>5-year rate: 24%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e434 class=n-a></a>0.69 (0.50-0.95)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e438 class=n-a></a>0.02</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e441 class=n-a></a><a href="#ref-13">13</a></td></tr><tr><a name=d24316e446 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e448 class=n-a></a>MAGIC</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e451 class=n-a></a>503</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e454 class=n-a></a>ECX → surgery → ECX (n = 250)<br class=br>Surgery (n = 253)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e459 class=n-a></a>5-year rate: 36%<br class=br>5-year rate: 23%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e464 class=n-a></a>0.75 (0.60-0.93)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e468 class=n-a></a>0.009</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e471 class=n-a></a><a href="#ref-12">12</a></td></tr><tr><a name=d24316e476 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e478 class=n-a></a>INT 113</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e481 class=n-a></a>440</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e484 class=n-a></a>CF → surgery (n = 213)<br class=br>Surgery (n = 227)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e489 class=n-a></a>Median: 14 months<br class=br>Median: 16 months</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e494 class=n-a></a>1.04 (0.84-1.29)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e498 class=n-a></a>0.53</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e501 class=n-a></a><a href="#ref-15">15</a></td></tr><tr><a name=d24316e507 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e509 class=n-a></a>MRC OEO5</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e512 class=n-a></a>897</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e515 class=n-a></a>ECF → surgery (n = 446)<br class=br>CF → surgery (n = 451)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e520 class=n-a></a>3-year rate: 39%<br class=br>3-year rate: 42%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e525 class=n-a></a>0.92 (0.79-1.08)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e529 class=n-a></a>0.30</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e532 class=n-a></a><a href="#ref-14">14</a></td></tr><tr><a name=d24316e537 class=n-a></a><td align=left colspan=7 rowspan=1 valign=top><a name=d24316e539 class=n-a></a>Preoperative chemoradiotherapy</td></tr><tr><a name=d24316e543 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e545 class=n-a></a>CROSS</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e548 class=n-a></a>368</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e551 class=n-a></a>Taxol/carbo/41.4 Gy → surgery<br class=br>(n = 180)<br class=br>Surgery (n = 188)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e558 class=n-a></a>Median: 48 months<br class=br>Median: 24 months</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e563 class=n-a></a>0.68 (0.53-0.88)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e567 class=n-a></a>0.003</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e570 class=n-a></a><a href="#ref-18">18</a></td></tr><tr><a name=d24316e575 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e577 class=n-a></a>FFCD 9901</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e580 class=n-a></a>195</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e583 class=n-a></a>CF/45 Gy → surgery (n = 98)<br class=br>Surgery (n = 97)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e588 class=n-a></a>5-year rate: 41%<br class=br>5-year rate: 33%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e593 class=n-a></a>0.99 (0.69-1.30)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e597 class=n-a></a>0.94</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e600 class=n-a></a><a href="#ref-21">21</a></td></tr><tr><a name=d24316e605 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e607 class=n-a></a>CALGB 9781</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e610 class=n-a></a>56</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e613 class=n-a></a>CF/50.4 Gy → surgery (n = 30)<br class=br>Surgery (n = 26)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e618 class=n-a></a>5-year rate: 39%<br class=br>5-year rate: 16%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e623 class=n-a></a>- (0.17-0.68)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e627 class=n-a></a>0.002</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e630 class=n-a></a><a href="#ref-20">20</a></td></tr><tr><a name=d24316e635 class=n-a></a><td align=left colspan=7 rowspan=1 valign=top><a name=d24316e637 class=n-a></a>Preoperative chemotherapy vs. preoperative chemoradiotherapy</td></tr><tr><a name=d24316e642 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e644 class=n-a></a>POET</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e647 class=n-a></a>119</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e650 class=n-a></a>CF/30 Gy → surgery (n = 60)<br class=br>CF → surgery (n = 59)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e655 class=n-a></a>3-year rate: 47%<br class=br>3-year rate: 27%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e660 class=n-a></a>0.67 (0.47-1.07)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e664 class=n-a></a>0.07</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e667 class=n-a></a><a href="#ref-22">22</a></td></tr><tr><a name=d24316e672 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e674 class=n-a></a>Burmeister<br class=br><i>et al</i>.</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e681 class=n-a></a>75</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e684 class=n-a></a>CF/35 Gy → surgery (n = 39)<br class=br>CF → surgery (n = 36)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e689 class=n-a></a>Median: 32 months<br class=br>Median: 29 months</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e694 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e698 class=n-a></a>0.83</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e701 class=n-a></a><a href="#ref-23">23</a></td></tr><tr><a name=d24316e706 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e708 class=n-a></a>NeoRes</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e711 class=n-a></a>181</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e714 class=n-a></a>CF/40 Gy → surgery (n = 91)<br class=br>CF → surgery (n = 90)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e719 class=n-a></a>3-year rate: 47%<br class=br>3-year rate: 49%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e724 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e728 class=n-a></a>0.77</td><td align=left colspan=1 rowspan=1 valign=top><a name=d24316e731 class=n-a></a><a href="#ref-24">24</a></td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d24316e740 class=n-a></a><p id=d24316e742> CALGB, Cancer and Leukemia Group B; CF, cisplatin and 5 fluorouracil; CROSS, Chemoradiotherapy for esophageal Cancer Followed by Surgery Study; ECF, epirubicin, cisplatin, and fluorouracil; ECX, epirubicin, cisplatin and capecitabine; FFCD, Fédération Francophone de Cancérologie Digestive; FNCLCC, Fédération Nationales des Centres de Lutte Contre le Cancer; MAGIC, Medical Research Council Adjuvant Gastric Infusional Chemotherapy; MRC, United Kingdom Medical Research Council; POET, Preoperative Chemotherapy or Radiochemotherapy in Esophago-gastric Adenocarcinoma.</p></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d24316e751>Preoperative chemotherapy</h2><p class="" id=d24316e754>Several trials have produced mixed results. Firstly, the United Kingdom Medical Research Council (MRC) esophageal cancer trial (OEO2) recruited 802 patients (EAC: 67%) and randomly assigned them to two treatment groups: 400 to surgery plus perioperative chemotherapy—two cycles of FP (cisplatin and fluorouracil)—and 402 to surgery alone. As compared with the surgery group, the perioperative chemotherapy group had a favorable OS (5-year rate: 23% versus 17%; hazard ratio [HR] 0.84; 95% confidence interval [CI] 0.72 to 0.98; <i>P</i> = 0.03), thus showing only marginal benefit<sup><a href="#ref-10">10</a>,<a href="#ref-11">11</a></sup>. The other two trials added postoperative chemotherapy to preoperative chemotherapy. The Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) trial evaluated the effect of perioperative chemotherapy— three preoperative and three postoperative cycles of ECF (epirubicin, cisplatin, and fluorouracil)—for resectable gastro-esophageal (GE) adenocarcinoma<sup><a href="#ref-12">12</a></sup>. Five hundred and three patients were randomly assigned to two treatment groups: 250 to surgery plus perioperative chemotherapy and 253 to surgery alone. As compared with the surgery-alone group, the perioperative chemotherapy group had a favorable OS (5-year rate: 36% versus 23%; HR 0.75; 95% CI 0.60 to 0.93; <i>P</i> = 0.009). However, only 25% of patients in this trial had EAC or GE junction involvement. Finally, in the Fédération Nationales des Centres de Lutte Contre le Cancer/Fédération Francophone de Cancérologie Digestive (FNCLCC/FFCD) trial, 224 patients were randomly assigned to two treatment groups: 113 to surgery plus perioperative chemotherapy (two or three preoperative and three or four postoperative cycles of CF) and 111 to surgery alone<sup><a href="#ref-13">13</a></sup>. In this trial, 75% of patients had EAC. Compared with the surgery-alone group, the perioperative chemotherapy group had had a favorable OS (5-year rate: 38% versus 24%; HR 0.69; 95% CI 0.50 to 0.95; <i>P</i> = 0.02). Moreover, perioperative chemotherapy significantly increased the R0 resection rate (84% versus 73%; <i>P</i> = 0.04). These trial results were considered acceptable, and perioperative chemotherapy became standard therapy in Europe. Recently, the MRC-OEO5 trial compared two chemotherapy regimens: two cycles of FP and four cycles of ECX (epirubicin, cisplatin, and capecitabine)<sup><a href="#ref-14">14</a></sup>. The ECX group had a higher R0 resection rate and pCR; however, there was no OS benefit for ECF compared with FP (3-year rate: 42% versus 39%; HR 0.92; 95% CI 0.79 to 1.08; <i>P</i> = 0.30). Furthermore, chemotherapy toxicity was higher in the ECX group<sup><a href="#ref-14">14</a></sup>. This trial suggests that preoperative chemotherapy with more drugs and longer duration is not worthwhile and the addition of epirubicin does not provide any advantage.</p><p class="" id=d24316e796>The first and only study conducted in the US was the RTOG trial 8911 (USA Intergroup 113), which demonstrated no advantage from the addition of preoperative chemotherapy to surgery<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup>. Thus, enthusiasm for preoperative chemotherapy has been low in the US and preoperative chemoradiation has been favored.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d24316e809>Preoperative chemoradiation</h2><p class="" id=d24316e812>A prior meta-analysis proposed that preoperative chemoradiation may be beneficial; however, meta-analyses are only hypothesis-generating<sup><a href="#ref-17">17</a></sup>. In 2012, the Chemoradiotherapy for esophageal Cancer Followed by Surgery Study (CROSS) trial produced favorable results for patients who received preoperative chemoradiation over surgery alone<sup><a href="#ref-18">18</a></sup>. Three hundred sixty-eight resectable but selected patients with EC (EAC: 75%) were randomly assigned to two treatment groups: 180 to surgery plus preoperative chemoradiation and 188 to surgery alone. The long-term result of the CROSS study showed that the median OS for the preoperative chemoradiation group was significantly longer than that for the surgery-alone group (median of 48.6 versus 24.0 months; HR 0.68; 95% CI 0.53 to 0.88; <i>P</i> = 0.003)<sup><a href="#ref-19">19</a></sup>. Importantly, the benefit for patients with ESCC was higher than for patients with EAC: Median OS rates for patients with ESCC were 81.6 months in the preoperative chemoradiation group and 21.1 months in the surgery-alone group (HR 0.48; 95% CI 0.28 to 0.83; <i>P</i> = 0.008), whereas the rates for patients with EAC were 43.2 months in the preoperative chemoradiation group and 27.1 months in the surgery-alone group (HR 0.73; 95% CI 0.55 to 0.98; <i>P</i> = 0.038)<sup><a href="#ref-19">19</a></sup>. The rate of R0 resection increased because of preoperative chemoradiation. A previous prospective randomized CALGB 9781 trial compared surgery plus preoperative chemoradiation (cisplatin and fluorouracil with 50.4-Gy concurrent radiotherapy) and surgery alone and showed benefit for preoperative chemoradiation<sup><a href="#ref-20">20</a></sup>. However, this trial assessed only 56 patients (EAC: 75%).</p><p class="" id=d24316e845>The benefit from preoperative chemoradiation for patients with early-stage EC remains debatable. The result of the FFCD 9901 trial, which compared the surgery-alone group (n = 97, EAC: 28%) with the preoperative chemoradiation group (n = 98, EAC: 31%), unfortunately did not show an increase in the R0 resection rate or OS benefit but did have an increase in postoperative mortality<sup><a href="#ref-21">21</a></sup>.</p><p class="" id=d24316e852>The type of chemotherapy agents and radiation dose differ among trials. The CROSS study used paclitaxel and carboplatin plus 41.4-Gy concurrent radiotherapy; on the other hand, the FFCD 9901 study used CF plus 45-Gy concurrent radiotherapy. Although the OS benefit from preoperative chemotherapy is modest to marginal, the types of combinations have varied (FP or ECF regimen)<sup><a href="#ref-12">12</a>,<a href="#ref-13">13</a></sup>. In the current National Comprehensive Cancer Network guidelines, ECF has been downgraded on the basis of the OEO5 trial results<sup><a href="#ref-14">14</a></sup>. Importantly, no trial has been completed that compared preoperative chemotherapy with preoperative chemoradiation. An ongoing trial might settle this issue. The PROTECT (PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer) study (NCT02359968) is comparing carboplatin and paclitaxel with FOLFOX during radiation. Another phase II trial (NCT01843829) is comparing carboplatin and paclitaxel with oxaliplatin and capecitabine. Additionally, the Neo-AEGIS trial (NCT01726452) is currently comparing the CROSS regimen with the MAGIC regimen. Results are expected in the near future.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d24316e869>Chemotherapy and chemoradiation</h2><p class="" id=d24316e872>A recent meta-analysis compared preoperative chemoradiotherapy (n = 1,078) and chemotherapy (n = 1,141) for both EAC and ESCC, showing better OS of preoperative chemoradiation but not to a significant degree (HR 0.88; 95% CI 0.76 to 1.01; <i>P</i> = 0.07)<sup><a href="#ref-17">17</a></sup>. To date, three randomized trials have compared preoperative chemoradiotherapy with chemotherapy, but none showed a benefit in OS of preoperative chemoradiation. The Preoperative Chemotherapy or Radiochemotherapy in Esophago-gastric Adenocarcinoma (POET) trial failed to recruit a sufficient number to document an OS advantage for preoperative chemoradiation, and the trial had to be terminated early<sup><a href="#ref-22">22</a></sup>. The pCR rate was higher with preoperative chemoradiation compared with preoperative chemotherapy (15.6% versus 2.0%)<sup><a href="#ref-22">22</a></sup>. Another phase II trial also showed no benefit from preoperative chemoradiation for patients with EAC; the median OS was 32 months from preoperative chemoradiation compared with 29 months from preoperative chemotherapy (<i>P</i> = 0.83)<sup><a href="#ref-23">23</a></sup>. Another trial compared neoadjuvant chemotherapy with chemoradiotherapy in resectable cancer of the esophagus and gastric cardia patients (n = 181 with 73% EAC), and although chemoradiation resulted in a higher pCR rate (28% versus 9%), higher R0 resection rate (87% versus 74%), and a lower rate of lymph nodal metastases (35% versus 62%), there was no OS benefit (3-year OS: 49% versus 47%; <i>P</i> = 0.77)<sup><a href="#ref-24">24</a></sup>.</p><p class="" id=d24316e905>Our group retrospectively reviewed sequential phase II/III trials performed at the University of Texas M.D. Anderson Cancer Center, showing that compared with preoperative chemotherapy, preoperative chemoradiation exhibited a longer OS (<i>P</i> = 0.046) and disease-free survival (<i>P</i> = 0.015) and the higher pCR rate (<i>P</i> &lt;0.001)<sup><a href="#ref-25">25</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d24316e924>Induction chemotherapy followed by preoperative chemoradiation</h2><p class="" id=d24316e927>Our group had proposed a strategy of induction chemotherapy before preoperative chemoradiation<sup><a href="#ref-26">26</a></sup>. To document whether there is any benefit to the addition of induction chemotherapy, we reported a randomized phase II trial that compared induction chemotherapy followed by preoperative chemoradiation with preoperative chemoradiation only. One hundred twenty-six patients with localized EAC were randomly assigned to one of two groups. The median OS rates with and without induction chemotherapy were 43.6 and 45.6 months, respectively. The pCR rates were 13% in the no induction chemotherapy group and 26% in the induction chemotherapy group (<i>P</i> = 0.094), concluding that induction chemotherapy did not appear to benefit these patients<sup><a href="#ref-27">27</a></sup>. However, subgroup analysis showed that induction chemotherapy had a considerable benefit for only those patients who had a well-moderate differentiated tumor<sup><a href="#ref-28">28</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d24316e949>Preoperative treatment with molecular targeting drug</h2><p class="" id=d24316e952>Currently, there is no evidence that the addition of a targeted drug benefits to patients with localized EC. In patients with advanced EAC or gastric cancer, the ToGA (Trastuzumab for Gastric Cancer) trial showed that the addition of HER2 inhibitor, trastuzumab, to chemotherapy had modest benefit<sup><a href="#ref-29">29</a></sup>. However, the benefit of trastuzumab in the neoadjuvant setting is not established. In Japan, a phase II trial is evaluating S-1 plus cisplatin with or without trastuzumab in the neoadjuvant setting for HER2-positive gastric or esophagogastric junction adenocarcinoma<sup><a href="#ref-30">30</a></sup>. Epidermal growth factor receptor (EGFR) inhibitors have been evaluated in this setting<sup><a href="#ref-31">31</a>–<a href="#ref-34">34</a></sup> on the basis of a tantalizing phase II study which added cetuximab to chemoradiation and produced a pCR rate of 27%<sup><a href="#ref-33">33</a></sup>. However, two phase III trials that added an EGFR inhibitor to dCRT (definitive chemoradiation) failed to show survival benefit<sup><a href="#ref-31">31</a>,<a href="#ref-35">35</a></sup>. In addition, bevacizumab or erlotinib was evaluated with preoperative chemoradiation but did not demonstrate survival benefit or improvement in the pCR rate<sup><a href="#ref-36">36</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d24316e989>Future perspective</h2><p class="" id=d24316e992>Approximately 25% of patients who undergo preoperative chemoradiation achieve a pCR<sup><a href="#ref-18">18</a></sup>. If one could predict the possibility of pCR with a high level of certainty, then novel strategies to preserve the esophagus could be implemented. However, there are no useful clinical variables including positron emission tomographic (PET) changes and there are no reliable biomarkers for such a prediction at the moment. A clinical CR defined as endoscopic biopsies without cancer cells and PET scan with physiologic uptake provides an OS benefit<sup><a href="#ref-37">37</a></sup> but does not correlate with pCR<sup><a href="#ref-38">38</a></sup>. Therefore, we recommend that all patients eligible for surgery proceed to surgery after recovering from chemoradiation.</p><p class="" id=d24316e1007>Metabolic imaging with 18-fluorodeoxy-glucose positron emission computed tomography was assessed in various circumstances. Our group reported that PET parameters could correlate with prolonged OS but could not predict pCR<sup><a href="#ref-39">39</a></sup>. Interestingly, the Municon I and II trials evaluated treatment modifications according to PET responses for patients with EAC<sup><a href="#ref-40">40</a>,<a href="#ref-41">41</a></sup>. In the Municon II trial, PET non-responders from preoperative chemotherapy had chemoradiation before surgery; however, non-responders still had an unfavorable prognosis, suggesting that primary resistance cannot be overcome by simply changing therapy. Thus, in-depth study of the tumor biology is warranted and may contribute to personalize therapy.</p><p class="" id=d24316e1021>Recently, whole-genome analyses of EAC have been reported<sup><a href="#ref-42">42</a>–<a href="#ref-45">45</a></sup>. The Cancer Genome Atlas reported an integrated genomic landscape in EC, showing that genomic characterization of EAC was different from that of ESCC but similar to that of gastric cancer subtype “CIN, chromosomal instability”<sup><a href="#ref-46">46</a>,<a href="#ref-47">47</a></sup>. Mutations in <i>TP53</i>, <i>CDKN2A</i>, <i>ARID1A</i>, and <i>SMAD4</i> were common in EAC. Amplifications in <i>ERBB2</i>, <i>VEGFA</i>, <i>GATA4</i>, and <i>GATA6</i> were common in EAC. A positive result for microsatellite instability or Epstein-Barr virus was rare in EAC. However, there were some differences between EAC and gastric cancer subtyped with CIN. Compared with gastric cancer, EAC had more frequent CpG hyper-methylation phenotype, <i>VEGFA</i> and <i>MYC</i> amplifications and mutation of <i>SMARCA4</i>, deletion of tumor suppressor <i>RUNX1</i>, <i>FHIT</i>, and <i>WWOX</i>, and lower <i>APC</i> pathway activation<sup><a href="#ref-46">46</a></sup>. The molecular features of EAC were significantly different from that of ESCC. ESCC had significantly mutated genes, such as <i>TP53</i>, <i>NFE2L2</i>, <i>MLL2</i>, <i>ZNF750</i>, <i>NOTCH1</i>, and <i>TGFBR2</i>, and specific somatic copy number alterations, such as amplifications of SOX2, TERT, FGFR1, MDM2, and NKX2-1 and deletion of RB1. Compared with EAC, inactivation of CDKN2A, amplification of CCND1 and TP63/SOX2, and alterations of histone-modifying factors were more common in ESCC; conversely, ERBB2 alterations were rare, suggesting that molecular targeting can differ between EAC and ESCC<sup><a href="#ref-46">46</a></sup>. Secrier <i>et al</i>. reported whole-genome sequencing in 129 EAC samples and classified EAC into three groups: C&gt;A/T dominant (29%), DNA damage repair (DDR) impaired (18%), and mutagenic (53%)<sup><a href="#ref-45">45</a></sup>. The report recommends that, in some patients, the combination of anti-ERBB2 and anti-MET inhibition might prove useful. In the presence of DDR impairment, inhibition by poly ADP ribose polymerase (PARP) inhibitor in combination with DNA-damaging agent might prove useful. Recently, immune-checkpoint pathways, such as T lymphocyte-associated antigen 4 (CTLA-4) and programmed death protein 1/its ligand (PD-1/PD-L1), have received much attention<sup><a href="#ref-48">48</a></sup>. Therefore, tumors that have high mutation load may be amenable to immune-checkpoint inhibitors<sup><a href="#ref-49">49</a></sup>.</p><p class="" id=d24316e1128>Several biomarkers that may be associated with response to preoperative therapy have been explored<sup><a href="#ref-50">50</a></sup>. For instance, 3′-untranslated region polymorphisms of thymidylate synthase may predict a response to 5-fluorouracil (5-FU)-based chemoradiation<sup><a href="#ref-51">51</a></sup>. Overexpression of excision repair cross-complementation group 1 may be associated with chemoradiation response, especially with platinum agent<sup><a href="#ref-52">52</a></sup>. MicroRNAs also have potential as predictive markers<sup><a href="#ref-53">53</a></sup>. Hale <i>et al</i>. reported that the proportion of tumor in biopsy tissue can predict preoperative chemotherapy response<sup><a href="#ref-54">54</a></sup>; however, these data need to be validated and combined with biomarkers.</p><p class="" id=d24316e1156>Recently, liquid biopsy has been actively studied and is of considerable interest<sup><a href="#ref-55">55</a></sup>. Tumor-derived biomarkers in the bloodstream, such as circulating tumor cells (CTCs), cell-free DNA (ctDNA), and exosomes, have the potential to predict early treatment response<sup><a href="#ref-56">56</a>,<a href="#ref-57">57</a></sup>. For instance, in several cancers, changes in CTC count were associated with response to treatment<sup><a href="#ref-58">58</a>,<a href="#ref-59">59</a></sup>. In colorectal cancer, during treatment, mutation or copy number status in ctDNA can be dynamically monitored<sup><a href="#ref-60">60</a>,<a href="#ref-61">61</a></sup>. Further studies and clinical applications are expected.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d24316e1187>Conclusions</h2><p class="" id=d24316e1190>This review described an understanding of preoperative therapy for EC. The benefits of preoperative treatment, and preoperative chemoradiation in particular, have been established. Currently, preoperative chemoradiation is preferred over preoperative chemotherapy in the US. Head-to-head comparison of preoperative chemotherapy versus preoperative chemoradiation is not completed as it is a subject of ongoing trials. A further challenge is to identify patients who are destined to achieve a pCR. CTCs or ctDNA might prove useful in surveillance after therapy and occasionally for selection of therapy.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d24316e1 class=n-a></a><h2 class=main-title id=d24520>Author contributions</h2><p class=metadata-entry><a name=d24316e130 class=n-a></a><p id=d24316e132> KH helped to conceive the study and prepared the first draft of the manuscript. DK and JA helped to conceive the study. All authors contributed to the preparation of the manuscript and were involved in the revision of the draft and have agreed to the final content.</p></p></div><div class=back-section><a name=d24316e1 class=n-a></a><h2 class=main-title id=d24524>Competing interests</h2><p class=metadata-entry><a name=d24316e136 class=n-a></a><p id=d24316e138> The authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d24316e1 class=n-a></a><h2 class=main-title id=d24526>Grant information</h2><p>This work was supported by generous grants from the Caporella, Dallas, Sultan, Park, Smith, Frazier, Oaks, Vanstekelenberg, Planjery, and Cantu Families. From the Schecter Private Foundation, Rivercreek Foundation, Kevin Fund, Myer Fund, Dio Fund, Milrod Fund, and Multidisciplinary Grants from the University of Texas M. D. Anderson Cancer Center, Houston, USA. Supported in part by the National Cancer Institute and Department of Defense awards CA138671, CA172741, CA129926, CA150334 (JAA). Supported by a grant from Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers from Japan Society for the Promotion of Science (KH).</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript</i>.</p></div><div class=back-section><a name=d24316e1197 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d24723>References</h2><div class="section ref-list"><a name=d24316e1197 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d24316e1204 class=n-a></a>Ferlay J, Soerjomataram I, Dikshit R, <i> et al.</i>: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. <i>Int J Cancer.</i> 2015; <b>136</b>(5): E359–86. <a target=xrefwindow id=d24316e1215 href="http://www.ncbi.nlm.nih.gov/pubmed/25220842">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1218 href="http://dx.doi.org/10.1002/ijc.29210">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d24316e1227 class=n-a></a>Lagergren J, Bergström R, Lindgren A, <i> et al.</i>: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. <i>N Engl J Med.</i> 1999; <b>340</b>(11): 825–31. <a target=xrefwindow id=d24316e1238 href="http://www.ncbi.nlm.nih.gov/pubmed/10080844">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1241 href="http://dx.doi.org/10.1056/NEJM199903183401101">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d24316e1250 class=n-a></a>Hirst J, Smithers BM, Gotley DC, <i> et al.</i>: Defining cure for esophageal cancer: analysis of actual 5-year survivors following esophagectomy. <i>Ann Surg Oncol.</i> 2011; <b>18</b>(6): 1766–74. <a target=xrefwindow id=d24316e1261 href="http://www.ncbi.nlm.nih.gov/pubmed/21213056">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1264 href="http://dx.doi.org/10.1245/s10434-010-1508-z">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d24316e1273 class=n-a></a>Ajani JA, D'Amico TA, Almhanna K, <i> et al.</i>: Esophageal and esophagogastric junction cancers, version 1.2015. <i>J Natl Compr Canc Netw.</i> 2015; <b>13</b>(2): 194–227. <a target=xrefwindow id=d24316e1284 href="http://www.ncbi.nlm.nih.gov/pubmed/25691612">PubMed Abstract </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d24316e1293 class=n-a></a>Mariette C, Balon JM, Piessen G, <i> et al.</i>: Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. <i>Cancer.</i> 2003; <b>97</b>(7): 1616–23. <a target=xrefwindow id=d24316e1304 href="http://www.ncbi.nlm.nih.gov/pubmed/12655517">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1307 href="http://dx.doi.org/10.1002/cncr.11228">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d24316e1317 class=n-a></a>O'Sullivan GC, Sheehan D, Clarke A, <i> et al.</i>: Micrometastases in esophagogastric cancer: high detection rate in resected rib segments. <i>Gastroenterology.</i> 1999; <b>116</b>(3): 543–8. <a target=xrefwindow id=d24316e1328 href="http://www.ncbi.nlm.nih.gov/pubmed/10029612">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1331 href="http://dx.doi.org/10.1016/S0016-5085(99)70175-7">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d24316e1340 class=n-a></a>Rice TW, Rusch VW, Apperson-Hansen C, <i> et al.</i>: Worldwide esophageal cancer collaboration. <i>Dis Esophagus.</i> 2009; <b>22</b>(1): 1–8. <a target=xrefwindow id=d24316e1351 href="http://www.ncbi.nlm.nih.gov/pubmed/19196264">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1354 href="http://dx.doi.org/10.1111/j.1442-2050.2008.00901.x">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d24316e1363 class=n-a></a>Donahue JM, Nichols FC, Li Z, <i> et al.</i>: Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival. <i>Ann Thorac Surg.</i> 2009; <b>87</b>(2): 392–8; discussion 398–9. <a target=xrefwindow id=d24316e1374 href="http://www.ncbi.nlm.nih.gov/pubmed/19161745">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1377 href="http://dx.doi.org/10.1016/j.athoracsur.2008.11.001">Publisher Full Text </a> | <a target=xrefwindow id=d24316e1381 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2930775">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d24316e1390 class=n-a></a>Berger AC, Farma J, Scott WJ, <i> et al.</i>: Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. <i>J Clin Oncol.</i> 2005; <b>23</b>(19): 4330–7. <a target=xrefwindow id=d24316e1401 href="http://www.ncbi.nlm.nih.gov/pubmed/15781882">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1404 href="http://dx.doi.org/10.1200/JCO.2005.05.017">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d24316e1413 class=n-a></a>Medical Research Council Oesophageal Cancer Working Group: Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. <i>Lancet.</i> 2002; <b>359</b>(9319): 1727–33. <a target=xrefwindow id=d24316e1421 href="http://www.ncbi.nlm.nih.gov/pubmed/12049861">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1424 href="http://dx.doi.org/10.1016/S0140-6736(02)08651-8">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d24316e1433 class=n-a></a>Allum WH, Stenning SP, Bancewicz J, <i> et al.</i>: Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. <i>J Clin Oncol.</i> 2009; <b>27</b>(30): 5062–7. <a target=xrefwindow id=d24316e1444 href="http://www.ncbi.nlm.nih.gov/pubmed/19770374">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1447 href="http://dx.doi.org/10.1200/JCO.2009.22.2083">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/14646"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e1457 class=n-a></a>Cunningham D, Allum WH, Stenning SP, <i> et al.</i>: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. <i>N Engl J Med.</i> 2006; <b>355</b>(1): 11–20. <a target=xrefwindow id=d24316e1468 href="http://www.ncbi.nlm.nih.gov/pubmed/16822992">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1471 href="http://dx.doi.org/10.1056/NEJMoa055531">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/14646">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/10541957"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e1484 class=n-a></a>Ychou M, Boige V, Pignon JP, <i> et al.</i>: Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. <i>J Clin Oncol.</i> 2011; <b>29</b>(13): 1715–21. <a target=xrefwindow id=d24316e1495 href="http://www.ncbi.nlm.nih.gov/pubmed/21444866">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1498 href="http://dx.doi.org/10.1200/JCO.2010.33.0597">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/10541957">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d24316e1511 class=n-a></a>Alderson D, Langley RE, Nankivell MG, <i> et al.</i>: Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072). <i>J Clin Oncol.</i> 2015; <b>33</b>(suppl): abstr 4002. <a target=xrefwindow id=d24316e1522 href="http://meetinglibrary.asco.org/content/149773-156">Reference Source</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d24316e1531 class=n-a></a>Kelsen DP, Ginsberg R, Pajak TF, <i> et al.</i>: Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. <i>N Engl J Med.</i> 1998; <b>339</b>(27): 1979–84. <a target=xrefwindow id=d24316e1542 href="http://www.ncbi.nlm.nih.gov/pubmed/9869669">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1545 href="http://dx.doi.org/10.1056/NEJM199812313392704">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d24316e1554 class=n-a></a>Kelsen DP, Winter KA, Gunderson LL, <i> et al.</i>: Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. <i>J Clin Oncol.</i> 2007; <b>25</b>(24): 3719–25. <a target=xrefwindow id=d24316e1565 href="http://www.ncbi.nlm.nih.gov/pubmed/17704421">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1568 href="http://dx.doi.org/10.1200/JCO.2006.10.4760">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d24316e1577 class=n-a></a>Sjoquist KM, Burmeister BH, Smithers BM, <i> et al.</i>: Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. <i>Lancet Oncol.</i> 2011; <b>12</b>(7): 681–92. <a target=xrefwindow id=d24316e1588 href="http://www.ncbi.nlm.nih.gov/pubmed/21684205">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1591 href="http://dx.doi.org/10.1016/S1470-2045(11)70142-5">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717147902"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e1601 class=n-a></a>van Hagen P, Hulshof MC, van Lanschot JJ, <i> et al.</i>: Preoperative chemoradiotherapy for esophageal or junctional cancer. <i>N Engl J Med.</i> 2012; <b>366</b>(22): 2074–84. <a target=xrefwindow id=d24316e1612 href="http://www.ncbi.nlm.nih.gov/pubmed/22646630">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1615 href="http://dx.doi.org/10.1056/NEJMoa1112088">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717147902">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725707551"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e1628 class=n-a></a>Shapiro J, van Lanschot JJ, Hulshof MC, <i> et al.</i>: Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. <i>Lancet Oncol.</i> 2015; <b>16</b>(9): 1090–8. <a target=xrefwindow id=d24316e1639 href="http://www.ncbi.nlm.nih.gov/pubmed/26254683">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1642 href="http://dx.doi.org/10.1016/S1470-2045(15)00040-6">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725707551">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d24316e1655 class=n-a></a>Tepper J, Krasna MJ, Niedzwiecki D, <i> et al.</i>: Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. <i>J Clin Oncol.</i> 2008; <b>26</b>(7): 1086–92. <a target=xrefwindow id=d24316e1666 href="http://www.ncbi.nlm.nih.gov/pubmed/18309943">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1669 href="http://dx.doi.org/10.1200/JCO.2007.12.9593">Publisher Full Text </a> | <a target=xrefwindow id=d24316e1673 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5126644">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718475545"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e1682 class=n-a></a>Mariette C, Dahan L, Mornex F, <i> et al.</i>: Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901. <i>J Clin Oncol.</i> 2014; <b>32</b>(23): 2416–22. <a target=xrefwindow id=d24316e1693 href="http://www.ncbi.nlm.nih.gov/pubmed/24982463">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1696 href="http://dx.doi.org/10.1200/JCO.2013.53.6532">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718475545">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d24316e1709 class=n-a></a>Stahl M, Walz MK, Stuschke M, <i> et al.</i>: Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. <i>J Clin Oncol.</i> 2009; <b>27</b>(6): 851–6. <a target=xrefwindow id=d24316e1720 href="http://www.ncbi.nlm.nih.gov/pubmed/19139439">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1723 href="http://dx.doi.org/10.1200/JCO.2008.17.0506">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d24316e1732 class=n-a></a>Burmeister BH, Thomas JM, Burmeister EA, <i> et al.</i>: Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial. <i>Eur J Cancer.</i> 2011; <b>47</b>(3): 354–60. <a target=xrefwindow id=d24316e1743 href="http://www.ncbi.nlm.nih.gov/pubmed/21084184">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1746 href="http://dx.doi.org/10.1016/j.ejca.2010.09.009">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726084731"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e1756 class=n-a></a>Klevebro F, Alexandersson von Döbeln G, Wang N, <i> et al.</i>: A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction. <i>Ann Oncol.</i> 2016; <b>27</b>(4): 660–7. <a target=xrefwindow id=d24316e1767 href="http://www.ncbi.nlm.nih.gov/pubmed/26782957">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1770 href="http://dx.doi.org/10.1093/annonc/mdw010">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726084731">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d24316e1783 class=n-a></a>Swisher SG, Hofstetter W, Komaki R, <i> et al.</i>: Improved long-term outcome with chemoradiotherapy strategies in esophageal cancer. <i>Ann Thorac Surg.</i> 2010; <b>90</b>(3): 892–8; discussion 898–9. <a target=xrefwindow id=d24316e1794 href="http://www.ncbi.nlm.nih.gov/pubmed/20732514">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1797 href="http://dx.doi.org/10.1016/j.athoracsur.2010.04.061">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d24316e1806 class=n-a></a>Ajani JA, Komaki R, Putnam JB, <i> et al.</i>: A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction. <i>Cancer.</i> 2001; <b>92</b>(2): 279–86. <a target=xrefwindow id=d24316e1817 href="http://www.ncbi.nlm.nih.gov/pubmed/11466680">PubMed Abstract </a> | <a target="xrefwindow" id="d24316e1820" href="http://dx.doi.org/10.1002/1097-0142(20010715)92:2<279::AID-CNCR1320&gt;3.0.CO;2-2">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718085314"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e1829 class=n-a></a>Ajani JA, Xiao L, Roth JA, <i> et al.</i>: A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer. <i>Ann Oncol.</i> 2013; <b>24</b>(11): 2844–9. <a target=xrefwindow id=d24316e1840 href="http://www.ncbi.nlm.nih.gov/pubmed/23975663">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1843 href="http://dx.doi.org/10.1093/annonc/mdt339">Publisher Full Text </a> | <a target=xrefwindow id=d24316e1847 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3937600">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718085314">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d24316e1860 class=n-a></a>Shimodaira Y, Slack RS, Chen HC, <i> et al.</i>: Influence of induction chemotherapy (IC) in trimodality-eligible esophageal cancer patients: Secondary analysis of a randomized trial. <i>J Clin Oncol.</i> 2016; <b>34</b>(suppl): abstr 4027. <a target=xrefwindow id=d24316e1871 href="http://meetinglibrary.asco.org/content/163791-176">Reference Source</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/5004956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e1880 class=n-a></a>Bang YJ, van Cutsem E, Feyereislova A, <i> et al.</i>: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. <i>Lancet.</i> 2010; <b>376</b>(9742): 687–97. <a target=xrefwindow id=d24316e1891 href="http://www.ncbi.nlm.nih.gov/pubmed/20728210">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1894 href="http://dx.doi.org/10.1016/S0140-6736(10)61121-X">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/5004956">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d24316e1908 class=n-a></a>Kataoka K, Tokunaga M, Mizusawa J, <i> et al.</i>: A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301 (Trigger Study). <i>Jpn J Clin Oncol.</i> 2015; <b>45</b>(11): 1082–6. <a target=xrefwindow id=d24316e1919 href="http://www.ncbi.nlm.nih.gov/pubmed/26355164">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1922 href="http://dx.doi.org/10.1093/jjco/hyv134">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727304561"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e1931 class=n-a></a>Crosby T, Hurt CN, Falk S, <i> et al.</i>: Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer. <i>Br J Cancer.</i> 2017; <b>116</b>(6): 709–716. <a target=xrefwindow id=d24316e1942 href="http://www.ncbi.nlm.nih.gov/pubmed/28196063">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1945 href="http://dx.doi.org/10.1038/bjc.2017.21">Publisher Full Text </a> | <a target=xrefwindow id=d24316e1949 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5355926">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727304561">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d24316e1962 class=n-a></a>Ruhstaller T, Pless M, Dietrich D, <i> et al.</i>: Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06). <i>J Clin Oncol.</i> 2011; <b>29</b>(6): 626–31. <a target=xrefwindow id=d24316e1973 href="http://www.ncbi.nlm.nih.gov/pubmed/21205757">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1976 href="http://dx.doi.org/10.1200/JCO.2010.31.9715">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d24316e1985 class=n-a></a>Safran H, Suntharalingam M, Dipetrillo T, <i> et al.</i>: Cetuximab with concurrent chemoradiation for esophagogastric cancer: assessment of toxicity. <i>Int J Radiat Oncol Biol Phys.</i> 2008; <b>70</b>(2): 391–5. <a target=xrefwindow id=d24316e1996 href="http://www.ncbi.nlm.nih.gov/pubmed/17980508">PubMed Abstract </a> | <a target=xrefwindow id=d24316e1999 href="http://dx.doi.org/10.1016/j.ijrobp.2007.07.2325">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718130154"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e2008 class=n-a></a>Becerra CR, Hanna N, McCollum AD, <i> et al.</i>: A phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GE junction carcinomas: Hoosier Oncology Group G05-92. <i>J Thorac Oncol.</i> 2013; <b>8</b>(11): 1425–9. <a target=xrefwindow id=d24316e2019 href="http://www.ncbi.nlm.nih.gov/pubmed/24084441">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2022 href="http://dx.doi.org/10.1097/JTO.0b013e3182a46c3b">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718130154">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d24316e2035 class=n-a></a>Suntharalingam M, Winter K, Ilson DH, <i> et al.</i>: The initial report of RTOG 0436: A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery. <i>J Clin Oncol.</i> 2014; <b>32</b>(suppl 3): abstr LBA6. <a target=xrefwindow id=d24316e2046 href="http://dx.doi.org/10.1200/jco.2014.32.3_suppl.lba6">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727478945"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e2056 class=n-a></a>Bendell JC, Meluch A, Peyton J, <i> et al.</i>: A phase II trial of preoperative concurrent chemotherapy/radiation therapy plus bevacizumab/erlotinib in the treatment of localized esophageal cancer. <i>Clin Adv Hematol Oncol.</i> 2012; <b>10</b>(7): 430–7. <a target=xrefwindow id=d24316e2067 href="http://www.ncbi.nlm.nih.gov/pubmed/22895283">PubMed Abstract </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727478945">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d24316e2080 class=n-a></a>Taketa T, Correa AM, Suzuki A, <i> et al.</i>: Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation. <i>Oncology.</i> 2012; <b>83</b>(5): 300–4. <a target=xrefwindow id=d24316e2091 href="http://www.ncbi.nlm.nih.gov/pubmed/22964903">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2094 href="http://dx.doi.org/10.1159/000341353">Publisher Full Text </a> | <a target=xrefwindow id=d24316e2098 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3832345">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d24316e2107 class=n-a></a>Suzuki A, Xiao L, Taketa T, <i> et al.</i>: Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation. <i>Ann Oncol.</i> 2013; <b>24</b>(11): 2854–9. <a target=xrefwindow id=d24316e2118 href="http://www.ncbi.nlm.nih.gov/pubmed/23994746">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2121 href="http://dx.doi.org/10.1093/annonc/mdt340">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d24316e2130 class=n-a></a>Elimova E, Wang X, Etchebehere E, <i> et al.</i>: 18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients. <i>Eur J Cancer.</i> 2015; <b>51</b>(17): 2545–52. <a target=xrefwindow id=d24316e2141 href="http://www.ncbi.nlm.nih.gov/pubmed/26321501">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2144 href="http://dx.doi.org/10.1016/j.ejca.2015.07.044">Publisher Full Text </a> | <a target=xrefwindow id=d24316e2148 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4663130">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d24316e2157 class=n-a></a>zum Büschenfelde CM, Herrmann K, Schuster T, <i> et al.</i>: <sup>18</sup>F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial. <i>J Nucl Med.</i> 2011; <b>52</b>(8): 1189–96. <a target=xrefwindow id=d24316e2171 href="http://www.ncbi.nlm.nih.gov/pubmed/21764790">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2175 href="http://dx.doi.org/10.2967/jnumed.110.085803">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d24316e2184 class=n-a></a>Lordick F, Ott K, Krause BJ, <i> et al.</i>: PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. <i>Lancet Oncol.</i> 2007; <b>8</b>(9): 797–805. <a target=xrefwindow id=d24316e2195 href="http://www.ncbi.nlm.nih.gov/pubmed/17693134">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2198 href="http://dx.doi.org/10.1016/S1470-2045(07)70244-9">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718113621"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e2208 class=n-a></a>Dulak AM, Stojanov P, Peng S, <i> et al.</i>: Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. <i>Nat Genet.</i> 2013; <b>45</b>(5): 478–86. <a target=xrefwindow id=d24316e2219 href="http://www.ncbi.nlm.nih.gov/pubmed/23525077">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2222 href="http://dx.doi.org/10.1038/ng.2591">Publisher Full Text </a> | <a target=xrefwindow id=d24316e2226 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3678719">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718113621">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725063609"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e2239 class=n-a></a>Nones K, Waddell N, Wayte N, <i> et al.</i>: Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis. <i>Nat Commun.</i> 2014; <b>5</b>: 5224. <a target=xrefwindow id=d24316e2250 href="http://www.ncbi.nlm.nih.gov/pubmed/25351503">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2253 href="http://dx.doi.org/10.1038/ncomms6224">Publisher Full Text </a> | <a target=xrefwindow id=d24316e2257 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4596003">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725063609">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725766391"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e2270 class=n-a></a>Wang K, Johnson A, Ali SM, <i> et al.</i>: Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences. <i>Oncologist.</i> 2015; <b>20</b>(10): 1132–9. <a target=xrefwindow id=d24316e2281 href="http://www.ncbi.nlm.nih.gov/pubmed/26336083">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2284 href="http://dx.doi.org/10.1634/theoncologist.2015-0156">Publisher Full Text </a> | <a target=xrefwindow id=d24316e2288 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4591943">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725766391">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726711328"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e2301 class=n-a></a>Secrier M, Li X, de Silva N, <i> et al.</i>: Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance. <i>Nat Genet.</i> 2016; <b>48</b>(10): 1131–41. <a target=xrefwindow id=d24316e2312 href="http://www.ncbi.nlm.nih.gov/pubmed/27595477">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2315 href="http://dx.doi.org/10.1038/ng.3659">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726711328">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727165156"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e2328 class=n-a></a>Cancer Genome Atlas Research Network, Analysis Working Group: Asan University, BC Cancer Agency, <i>et al.</i>: Integrated genomic characterization of oesophageal carcinoma. <i>Nature.</i> 2017; <b>541</b>(7636): 169–75. <a target=xrefwindow id=d24316e2339 href="http://www.ncbi.nlm.nih.gov/pubmed/28052061">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2342 href="http://dx.doi.org/10.1038/nature20805">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727165156">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718513254"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e2355 class=n-a></a>Cancer Genome Atlas Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. <i>Nature.</i> 2014; <b>513</b>(7517): 202–9. <a target=xrefwindow id=d24316e2363 href="http://www.ncbi.nlm.nih.gov/pubmed/25079317">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2366 href="http://dx.doi.org/10.1038/nature13480">Publisher Full Text </a> | <a target=xrefwindow id=d24316e2369 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4170219">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718513254">F1000 Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725419658"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e2383 class=n-a></a>Sharma P, Allison JP: The future of immune checkpoint therapy. <i>Science.</i> 2015; <b>348</b>(6230): 56–61. <a target=xrefwindow id=d24316e2391 href="http://www.ncbi.nlm.nih.gov/pubmed/25838373">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2394 href="http://dx.doi.org/10.1126/science.aaa8172">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725419658">F1000 Recommendation</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726043252"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e2407 class=n-a></a>Becht E, Giraldo NA, Dieu-Nosjean M, <i> et al.</i>: Cancer immune contexture and immunotherapy. <i>Curr Opin Immunol.</i> 2016; <b>39</b>: 7–13. <a target=xrefwindow id=d24316e2418 href="http://www.ncbi.nlm.nih.gov/pubmed/26708937">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2421 href="http://dx.doi.org/10.1016/j.coi.2015.11.009">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726043252">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d24316e2434 class=n-a></a>Fareed KR, Kaye P, Soomro IN, <i> et al.</i>: Biomarkers of response to therapy in oesophago-gastric cancer. <i>Gut.</i> 2009; <b>58</b>(1): 127–43. <a target=xrefwindow id=d24316e2445 href="http://www.ncbi.nlm.nih.gov/pubmed/19091831">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2448 href="http://dx.doi.org/10.1136/gut.2008.155861">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d24316e2457 class=n-a></a>Liao Z, Liu H, Swisher SG, <i> et al.</i>: Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation. <i>Int J Radiat Oncol Biol Phys.</i> 2006; <b>64</b>(3): 700–8. <a target=xrefwindow id=d24316e2468 href="http://www.ncbi.nlm.nih.gov/pubmed/16242255">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2471 href="http://dx.doi.org/10.1016/j.ijrobp.2005.08.008">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d24316e2480 class=n-a></a>Joshi MB, Shirota Y, Danenberg KD, <i> et al.</i>: High gene expression of <i>TS1</i>, <i>GSTP1</i>, and <i>ERCC1</i> are risk factors for survival in patients treated with trimodality therapy for esophageal cancer. <i>Clin Cancer Res.</i> 2005; <b>11</b>(6): 2215–21. <a target=xrefwindow id=d24316e2501 href="http://www.ncbi.nlm.nih.gov/pubmed/15788669">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2504 href="http://dx.doi.org/10.1158/1078-0432.CCR-04-1387">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d24316e2513 class=n-a></a>Skinner HD, Lee JH, Bhutani MS, <i> et al.</i>: A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma. <i>Cancer.</i> 2014; <b>120</b>(23): 3635–41. <a target=xrefwindow id=d24316e2524 href="http://www.ncbi.nlm.nih.gov/pubmed/25091571">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2527 href="http://dx.doi.org/10.1002/cncr.28911">Publisher Full Text </a> | <a target=xrefwindow id=d24316e2531 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4239178">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726869547"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e2541 class=n-a></a>Hale MD, Nankivell M, Hutchins GG, <i> et al.</i>: Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trial. <i>Oncotarget.</i> 2016; <b>7</b>(47): 77565–75. <a target=xrefwindow id=d24316e2552 href="http://www.ncbi.nlm.nih.gov/pubmed/27769054">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2555 href="http://dx.doi.org/10.18632/oncotarget.12723">Publisher Full Text </a> | <a target=xrefwindow id=d24316e2559 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5363605">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726869547">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725320763"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e2572 class=n-a></a>Reeh M, Effenberger KE, Koenig AM, <i> et al.</i>: Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer. <i>Ann Surg.</i> 2015; <b>261</b>(6): 1124–30. <a target=xrefwindow id=d24316e2583 href="http://www.ncbi.nlm.nih.gov/pubmed/25607767">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2586 href="http://dx.doi.org/10.1097/SLA.0000000000001130">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725320763">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d24316e2599 class=n-a></a>Alix-Panabières C, Pantel K: Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy. <i>Cancer Discov.</i> 2016; <b>6</b>(5): 479–91. <a target=xrefwindow id=d24316e2607 href="http://www.ncbi.nlm.nih.gov/pubmed/26969689">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2610 href="http://dx.doi.org/10.1158/2159-8290.CD-15-1483">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725798343"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e2619 class=n-a></a>Chaudhuri AA, Binkley MS, Osmundson EC, <i> et al.</i>: Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA. <i>Semin Radiat Oncol.</i> 2015; <b>25</b>(4): 305–12. <a target=xrefwindow id=d24316e2630 href="http://www.ncbi.nlm.nih.gov/pubmed/26384278">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2633 href="http://dx.doi.org/10.1016/j.semradonc.2015.05.001">Publisher Full Text </a> | <a target=xrefwindow id=d24316e2637 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4575502">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725798343">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718312122"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e2650 class=n-a></a>Bidard FC, Peeters DJ, Fehm T, <i> et al.</i>: Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. <i>Lancet Oncol.</i> 2014; <b>15</b>(4): 406–14. <a target=xrefwindow id=d24316e2661 href="http://www.ncbi.nlm.nih.gov/pubmed/24636208">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2664 href="http://dx.doi.org/10.1016/S1470-2045(14)70069-5">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718312122">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725402256"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e2677 class=n-a></a>Scher HI, Heller G, Molina A, <i> et al.</i>: Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer. <i>J Clin Oncol.</i> 2015; <b>33</b>(12): 1348–55. <a target=xrefwindow id=d24316e2688 href="http://www.ncbi.nlm.nih.gov/pubmed/25800753">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2691 href="http://dx.doi.org/10.1200/JCO.2014.55.3487">Publisher Full Text </a> | <a target=xrefwindow id=d24316e2695 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4397279">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725402256">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725528261"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e2709 class=n-a></a>Siravegna G, Mussolin B, Buscarino M, <i> et al.</i>: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. <i>Nat Med.</i> 2015; <b>21</b>(7): 795–801. <a target=xrefwindow id=d24316e2720 href="http://www.ncbi.nlm.nih.gov/pubmed/26030179">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2723 href="http://dx.doi.org/10.1038/nm.3870">Publisher Full Text </a> | <a target=xrefwindow id=d24316e2727 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4868598">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725528261">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718326090"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d24316e2740 class=n-a></a>Mohan S, Heitzer E, Ulz P, <i> et al.</i>: Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing. <i>PLoS Genet.</i> 2014; <b>10</b>(3): e1004271. <a target=xrefwindow id=d24316e2751 href="http://www.ncbi.nlm.nih.gov/pubmed/24676216">PubMed Abstract </a> | <a target=xrefwindow id=d24316e2754 href="http://dx.doi.org/10.1371/journal.pgen.1004271">Publisher Full Text </a> | <a target=xrefwindow id=d24316e2758 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3967949">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718326090">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 18 Apr 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-501.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-501.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Holcombe Boulevard, Texas, USA<br/> <sup>2</sup> Department of Gastroenterological Surgery, Kumamoto University, Jonjo, Kumamoto, Japan<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-501/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 18 Apr 2017, 6:501 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.10794.1">https://doi.org/10.12688/f1000research.10794.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Harada K <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the <a href="http://creativecommons.org/publicdomain/zero/1.0/" target=_blank data-test-id=box-data-licence-link>Creative Commons Zero "No rights reserved" data waiver</a> (CC0 1.0 Public domain dedication). </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=11640 data-id=10794 data-downloads="" data-views="" data-scholar="10.12688/f1000research.10794.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-501/v1/pdf?article_uuid=77efad69-4129-4e7f-a5ca-1922571cf1e8" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.10794.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Harada K, Mizrak Kaya D, Baba H and Ajani JA. Recent advances in preoperative management of esophageal adenocarcinoma [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):501 (<a href="https://doi.org/10.12688/f1000research.10794.1" target=_blank>https://doi.org/10.12688/f1000research.10794.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=10794 id=mobile-track-article-signin-10794 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/10794?target=/articles/6-501.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=11640 /> <input name=articleId type=hidden value=10794 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Rupert Langer</strong>, Institute of Pathology, Switzerland </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Efriede Bollschweiler</strong>, General, Visceral and Cancer Surgery, University of Cologne, Germany </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 18 Apr 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-501.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-501.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=22146-21902></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=22145-21900></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-501/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>18 Apr 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Rupert Langer</strong>, Institute of Pathology, Switzerland </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Efriede Bollschweiler</strong>, General, Visceral and Cancer Surgery, University of Cologne, Germany </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-501.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-501/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in preoperative management...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-501/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-501/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-501/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Harada K et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-501/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-501",
            templates : {
                twitter : "Recent advances in preoperative management of esophageal adenocarcinoma. Harada K et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-501/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in preoperative management of esophageal adenocarcinoma", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in preoperative management of esophageal adenocarcinoma", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/10794/11640")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "11640");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "21900": 0,
                           "21902": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "95ec39e3-50cb-4039-b533-fa7b23534ea9";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-501.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-501.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-501.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-501.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-501.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>